Loading…

Ypsomed AG has started production at its newly built plant in Schwerin, Germany, with an investment of about €81 million. The facility will produce insulin syringes and pump systems, and is expected to create 150 jobs.
“Das Schweizer Medizintechnik-Unternehmen Ypsomed startet am Donnerstag in seinem neu errichteten Werk in Schwerin die Produktion.”welt.de
Summarized from public sources; check the original articles before acting on it.